Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials

Haematologica. 2014 Jun;99(6):945-9. doi: 10.3324/haematol.2014.106013.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Polycythemia Vera / complications
  • Polycythemia Vera / drug therapy*
  • Randomized Controlled Trials as Topic
  • Thrombocythemia, Essential / complications
  • Thrombocythemia, Essential / drug therapy*
  • Treatment Outcome